79346215 - LEAPER

Information

• Trademark
• 79346215

• Source

• Serial Number

  79346215

• Registration Number

  7064525

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  May 07, 2022
  2 years ago

• Registration Date

  May 30, 2023
  a year ago

• Transaction Date

  August 06, 2023
  11 months ago

• Status Date

  May 30, 2023
  a year ago

• Published for Opposition Date

  March 14, 2023
  a year ago

• Location Date

  May 30, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  OSGOOD, KRYSTINA E

• Law Office Assigned Location Code

  N30

• Owners

  • EDIGENE INC

Case File Statements

• GS0051: Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, medicated dermatological preparations and substances, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use
• GS0421: Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics

Case File Event Statements

• 8/6/2023 - 11 months ago

  15 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 7/20/2023 - 11 months ago

  14 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 7/20/2023 - 11 months ago

  13 - FINAL DISPOSITION PROCESSED Type: FIMP

• 6/29/2023 - a year ago

  12 - GRANT OF PROTECTION CREATED, TO BE SENT TO IB Type: GPAR

• 5/30/2023 - a year ago

  11 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/15/2023 - a year ago

  10 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 3/14/2023 - a year ago

  9 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/22/2023 - a year ago

  8 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/22/2023 - a year ago

  7 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/22/2023 - a year ago

  6 - NOTICE OF PUBLICATION Type: NPUB

• 2/3/2023 - a year ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/2/2023 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 8/2/2022 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 7/29/2022 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/28/2022 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR